SHUKRA PHARMACEUTICALS
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Shukra Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.
4.97₹ 2.54
As on Jan 16, 2026, 4:01 PM IST
Shukra Pharmaceuticals Price Performance
Today's LowToday's High
₹51.08₹53.63
₹53.62
52 Weeks' Low52 Weeks' High
₹11.74₹65.26
₹53.62
Open Price
₹51.08
Prev. Close
₹51.08
Volume
2,35,859
Over the last 5 years, the share price of Shukra Pharmaceuticals has gained 202.04% CAGR. Over the past year, the corresponding return has been 174.06%.
Shukra Pharmaceuticals’s current P/E of 196.34x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Shukra Pharmaceuticals Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Shukra Pharmaceuticals | 7.71 | -0.17 | 49.82 | 153.40 | 174.06 | 306.21 | 202.04 |
| Sun Pharmaceutical Industries | -5.24 | -7.12 | 0.92 | -3.39 | -4.99 | 17.25 | 22.54 |
| Divi's Laboratories | -5.49 | -1.78 | -5.14 | -8.17 | 6.06 | 23.21 | 11.34 |
| Torrent Pharmaceuticals | -0.16 | 6.29 | 13.77 | 16.84 | 25.03 | 36.80 | 24.26 |
| Cipla | -4.29 | -7.25 | -10.27 | -6.23 | -3.38 | 9.66 | 11.16 |
| Lupin | -0.74 | 4.02 | 12.03 | 11.42 | 2.16 | 42.16 | 14.74 |
| Dr. Reddy's Laboratories | -2.34 | -7.90 | -4.32 | -6.49 | -11.94 | 10.87 | 2.52 |
| Mankind Pharma | -3.68 | 1.43 | -11.13 | -18.05 | -16.25 | 15.14 | 8.83 |
| Zydus Lifesciences | -4.39 | -5.80 | -11.20 | -10.27 | -11.88 | 25.50 | 12.20 |
| Alkem Laboratories | 0.75 | 3.98 | 4.79 | 18.38 | 12.29 | 24.33 | 13.48 |
| Aurobindo Pharma | -3.29 | -1.55 | 5.22 | 1.31 | 1.72 | 37.78 | 4.51 |
| Abbott India | -1.97 | -0.43 | -6.73 | -19.08 | 0.04 | 8.01 | 13.12 |
| Laurus Labs | -2.23 | 7.17 | 22.93 | 30.14 | 93.28 | 44.84 | 23.83 |
| Biocon | -0.26 | -3.48 | 5.84 | -3.40 | -1.43 | 14.59 | -3.77 |
| Glenmark Pharmaceuticals | -3.74 | 0.77 | 5.68 | -10.16 | 35.45 | 68.26 | 31.32 |
| GlaxoSmithKline Pharmaceuticals | -2.14 | -8.84 | -14.22 | -26.64 | 14.88 | 21.70 | 9.14 |
| Ipca Laboratories | -2.08 | 4.81 | 16.07 | 2.76 | -3.49 | 20.31 | 7.43 |
| Anthem Biosciences | -4.54 | -11.92 | -20.64 | -15.72 | -15.72 | -5.54 | -3.36 |
| Ajanta Pharma | -5.42 | 1.59 | 11.29 | -0.72 | -6.90 | 31.63 | 18.15 |
| Emcure Pharmaceuticals | 2.63 | 11.84 | 14.79 | 14.78 | 14.60 | 4.75 | 2.83 |
Over the last one year, Shukra Pharmaceuticals has gained 174.06% compared to peers like Sun Pharmaceutical Industries (-4.99%), Divi's Laboratories (6.06%), Torrent Pharmaceuticals (25.03%). From a 5 year perspective, Shukra Pharmaceuticals has outperformed peers relative to Sun Pharmaceutical Industries (22.54%) and Divi's Laboratories (11.34%).
Shukra Pharmaceuticals Financials
Shukra Pharmaceuticals Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 48.69 | 49.82 |
| 10 | 51.46 | 51.19 |
| 20 | 55.12 | 51.85 |
| 50 | 47.53 | 47.99 |
| 100 | 40.05 | 41.32 |
| 200 | 28.55 | 32.86 |
Shukra Pharmaceuticals Share Holding Pattern
In the latest quarter, Shukra Pharmaceuticals remained same as its previous close in promoter holding, while DII stake unchanged at 0.11%, FII holding unchanged at 0.00%, and public shareholding unchanged at 48.93% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Shukra Pharmaceuticals Corporate Actions
Date Time | Announcement |
|---|---|
| Jan 07, 2026, 7:25 PM IST | Shukra Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Jan 06, 2026, 1:12 AM IST | Shukra Pharma - Voting Result Along With Scrutinizer Report Of Postal Ballot |
| Jan 05, 2026, 8:44 PM IST | Shukra Pharma - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements |
| Dec 31, 2025, 12:51 AM IST | Shukra Pharma - Reconstitution Of Committees Of The Company. |
| Dec 31, 2025, 12:50 AM IST | Shukra Pharma - Announcement under Regulation 30 (LODR)-Change in Management |
About Shukra Pharmaceuticals
Shukra Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 04/03/1993 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24231GJ1993PLC019079 and registration number is 019079. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 32.59 Cr. and Equity Capital is Rs. 43.79 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- Address3rd Floor, Dev House, Opp. WIAA Office, Ahmedabad Gujarat 380054
- Contact
Management
- Mr. Dakshesh Rameshchandra ShahManaging Director
- Mrs. Payal Sujay MehtaExecutive Director
- Mr. Dhruvin ShahWhole Time Director
- Mr. Sanskruti Jayeshbhai PatelWhole Time Director
- Mrs. Anar Jayeshbhai PatelWhole Time Director
- Mrs. Shital ShahWhole Time Director
- Mrs. Bhoomiben PatelIndependent Director
- Mrs. Sonal Deepalbhai GandhiIndependent Director
- Mr. Sarjeevan Singh RathoreIndependent Director
- Mr. Jitendra Somchand ShahIndependent Director
- Mrs. Pinki Nirmal SagarIndependent Director
- Mrs. Ritu KapoorIndependent Director
FAQs on Shukra Pharmaceuticals Share Price
What is the share price of Shukra Pharmaceuticals?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Shukra Pharmaceuticals is ₹53.62 as on Jan 16, 2026.
What kind of stock is Shukra Pharmaceuticals?
The Shukra Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Shukra Pharmaceuticals?
The market cap of Shukra Pharmaceuticals is ₹2,347.91 Cr as on Jan 16, 2026.
What are today's High and Low prices of Shukra Pharmaceuticals?
Today’s highest and lowest price of Shukra Pharmaceuticals are ₹53.63 and ₹51.08.
What are the 52 Week High and 52 Week Low of Shukra Pharmaceuticals?
The 52-week high/low is the highest and lowest price at which Shukra Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of Shukra Pharmaceuticals is ₹65.26 and 52-week low of Shukra Pharmaceuticals is ₹11.74 as on Jan 16, 2026.
How has the Shukra Pharmaceuticals performed historically in terms of returns?
The Shukra Pharmaceuticals has shown returns of 4.97% over the past day, -0.17% for the past month, 49.82% over 3 months, 174.06% over 1 year, 306.21% across 3 years, and 202.04% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Shukra Pharmaceuticals?
P/E ratio of and PB ratio of Shukra Pharmaceuticals are 196.34 and 35.68 on Jan 16, 2026. While the company gives a dividend yield of 0.02 per annum.
✕
Market Pulse